Last reviewed · How we verify
High dose of Micardis®, once daily
High dose of Micardis®, once daily is a Small molecule drug developed by Boehringer Ingelheim. It is currently FDA-approved. Also known as: Telmisartan.
At a glance
| Generic name | High dose of Micardis®, once daily |
|---|---|
| Also known as | Telmisartan |
| Sponsor | Boehringer Ingelheim |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring (PHASE4)
- A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM) (PHASE4)
- Micardis®. Observational Study in Patients With Essential Hypertension
- A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM) (PHASE4)
- Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- High dose of Micardis®, once daily CI brief — competitive landscape report
- High dose of Micardis®, once daily updates RSS · CI watch RSS
- Boehringer Ingelheim portfolio CI
Frequently asked questions about High dose of Micardis®, once daily
What is High dose of Micardis®, once daily?
High dose of Micardis®, once daily is a Small molecule drug developed by Boehringer Ingelheim.
Who makes High dose of Micardis®, once daily?
High dose of Micardis®, once daily is developed and marketed by Boehringer Ingelheim (see full Boehringer Ingelheim pipeline at /company/boehringer-ingelheim).
Is High dose of Micardis®, once daily also known as anything else?
High dose of Micardis®, once daily is also known as Telmisartan.
What development phase is High dose of Micardis®, once daily in?
High dose of Micardis®, once daily is FDA-approved (marketed).
Related
- Manufacturer: Boehringer Ingelheim — full pipeline
- Also known as: Telmisartan
- Compare: High dose of Micardis®, once daily vs similar drugs
- Pricing: High dose of Micardis®, once daily cost, discount & access